Latest News - Neurological Biomarkers Market: Hospitals is expected to lead the End-user segment during 2024-2028

The Neurological Biomarkers Market is being driven by Rising incidence of neurological disorders

The Neurological Biomarkers Market is expected to grow at a CAGR of 13.01% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 7.82 billion. In the neurological disorders diagnostic landscape, CT scans have limitations, particularly in accurately detecting brain injuries such as Traumatic Brain Injuries (TBIs). This gap in detection has led to a surge in interest for alternative solutions. Enter neurological biomarkers, which through clinical trials and R&D, hold promise in delivering more precise results. Vendors are investing heavily in this area, recognizing the potential value of these advanced diagnostic tools in the market. 

Get more information on Neurological Biomarkers Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• End-user
  • Hospitals
  • Clinical diagnostic centers
  • Research organizations and others
• Indication
  • AD
  • PD
  • ASD
  • MS
  • Others
• Type
  • Genomic
  • Proteomic
  • Metabolomic
  • Imaging
  • Others
• Geography
  • North America
    • US
  • Europe
    • France
    • Germany
    • UK
  • Asia
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rising incidence of neurological disorders
• Growth in clinical trials for neurological disease-specific biomarkers
• Increasing initiatives and support from governments to improve neurological healthcare access

However, the market also witnesses some limitations, which are as follows:

• Unmet market needs for effective validation of biomarkers
• Reproducibility of biomarkers and tests leading to discrepancies
• Inherent challenges in neurological research

Benefits of Buying Global Neurological Biomarkers Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Neurological Biomarkers Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

In the realm of neurology, the discovery and utilization of reliable biomarkers have emerged as a critical component in advancing healthcare provision. Neurological biomarkers encompass various substances found in body fluids, such as blood, that can aid in the interpretation of patient conditions related to neurological disorders. These conditions include, but are not limited to, Autism, Epilepsy, Brain tumors, Stroke, Dementia, and Alzheimer's Disease (AD). The application of neurological biomarkers holds significant importance in ensuring patient privacy while providing accurate treatment outcomes. These markers can serve as diagnostic tools for early detection and rapid blood tests for monitoring disease progression. Moreover, they play a pivotal role in the development and implementation of targeted therapies and precision medicine. Despite the promising potential of neurological biomarkers, challenges persist, including adverse effects and delayed clinical trials. Healthcare providers and physicians continue to explore innovative approaches to address these challenges and maximize the benefits of these valuable indicators for brain health.

Market Research Overview

In the realm of global healthcare, the Neurological Biomarkers Market is a significant segment of the expansive Biotechnology Industry, as identified by Technavio. This market encompasses organizations involved in the research and development or production of neurological biomarkers, contributing to the larger Biotechnology sector. The healthcare industry's growth is propelled by several factors, including the increasing global population aging over 60 years, leading to a substantial rise in the demand for advanced healthcare solutions. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/